Szczepankiewicz, B.; Bąchor, R.; Pasławski, R.; Siwińska, N.; Pasławska, U.; Konieczny, A.; Szewczuk, Z.
Evaluation of Tryptic Podocin Peptide in Urine Sediment Using LC-MS-MRM Method as a Potential Biomarker of Glomerular Injury in Dogs with Clinical Signs of Renal and Cardiac Disorders. Molecules 2019, 24, 3088.
https://doi.org/10.3390/molecules24173088
AMA Style
Szczepankiewicz B, Bąchor R, Pasławski R, Siwińska N, Pasławska U, Konieczny A, Szewczuk Z.
Evaluation of Tryptic Podocin Peptide in Urine Sediment Using LC-MS-MRM Method as a Potential Biomarker of Glomerular Injury in Dogs with Clinical Signs of Renal and Cardiac Disorders. Molecules. 2019; 24(17):3088.
https://doi.org/10.3390/molecules24173088
Chicago/Turabian Style
Szczepankiewicz, Barbara, Remigiusz Bąchor, Robert Pasławski, Natalia Siwińska, Urszula Pasławska, Andrzej Konieczny, and Zbigniew Szewczuk.
2019. "Evaluation of Tryptic Podocin Peptide in Urine Sediment Using LC-MS-MRM Method as a Potential Biomarker of Glomerular Injury in Dogs with Clinical Signs of Renal and Cardiac Disorders" Molecules 24, no. 17: 3088.
https://doi.org/10.3390/molecules24173088
APA Style
Szczepankiewicz, B., Bąchor, R., Pasławski, R., Siwińska, N., Pasławska, U., Konieczny, A., & Szewczuk, Z.
(2019). Evaluation of Tryptic Podocin Peptide in Urine Sediment Using LC-MS-MRM Method as a Potential Biomarker of Glomerular Injury in Dogs with Clinical Signs of Renal and Cardiac Disorders. Molecules, 24(17), 3088.
https://doi.org/10.3390/molecules24173088
